nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—SIGMAR1—Progesterone—uterine cancer	0.266	0.375	CbGbCtD
Iloperidone—CYP3A7—Progesterone—uterine cancer	0.0755	0.106	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0755	0.106	CbGbCtD
Iloperidone—CYP3A5—Progesterone—uterine cancer	0.0566	0.0798	CbGbCtD
Iloperidone—CYP1A2—Progesterone—uterine cancer	0.0421	0.0594	CbGbCtD
Iloperidone—CYP2D6—Progesterone—uterine cancer	0.0347	0.0489	CbGbCtD
Iloperidone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0333	0.047	CbGbCtD
Iloperidone—CYP2E1—Etoposide—uterine cancer	0.0326	0.0459	CbGbCtD
Iloperidone—CYP3A5—Etoposide—uterine cancer	0.0253	0.0357	CbGbCtD
Iloperidone—CYP3A4—Progesterone—uterine cancer	0.0221	0.0311	CbGbCtD
Iloperidone—CYP1A2—Etoposide—uterine cancer	0.0189	0.0266	CbGbCtD
Iloperidone—CYP2D6—Doxorubicin—uterine cancer	0.0106	0.0149	CbGbCtD
Iloperidone—CYP3A4—Etoposide—uterine cancer	0.00988	0.0139	CbGbCtD
Iloperidone—CYP3A4—Doxorubicin—uterine cancer	0.00674	0.00949	CbGbCtD
Iloperidone—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00305	1	CbGdCrCtD
Iloperidone—HTR1D—artery—uterine cancer	0.00293	0.0588	CbGeAlD
Iloperidone—HTR7—artery—uterine cancer	0.00233	0.0468	CbGeAlD
Iloperidone—HTR2A—artery—uterine cancer	0.00145	0.0292	CbGeAlD
Iloperidone—SIGMAR1—myometrium—uterine cancer	0.00132	0.0265	CbGeAlD
Iloperidone—ADRA2C—myometrium—uterine cancer	0.00104	0.0208	CbGeAlD
Iloperidone—SIGMAR1—uterine cervix—uterine cancer	0.00103	0.0206	CbGeAlD
Iloperidone—SIGMAR1—smooth muscle tissue—uterine cancer	0.000997	0.02	CbGeAlD
Iloperidone—SIGMAR1—decidua—uterine cancer	0.000978	0.0196	CbGeAlD
Iloperidone—SIGMAR1—endometrium—uterine cancer	0.000928	0.0186	CbGeAlD
Iloperidone—SIGMAR1—mammalian vulva—uterine cancer	0.000898	0.018	CbGeAlD
Iloperidone—HTR7—epithelium—uterine cancer	0.000884	0.0177	CbGeAlD
Iloperidone—HTR1A—renal system—uterine cancer	0.000858	0.0172	CbGeAlD
Iloperidone—SIGMAR1—uterus—uterine cancer	0.000855	0.0172	CbGeAlD
Iloperidone—ADRA1A—epithelium—uterine cancer	0.000853	0.0171	CbGeAlD
Iloperidone—HTR7—smooth muscle tissue—uterine cancer	0.000852	0.0171	CbGeAlD
Iloperidone—HRH1—myometrium—uterine cancer	0.000841	0.0169	CbGeAlD
Iloperidone—ADRA2A—myometrium—uterine cancer	0.000826	0.0166	CbGeAlD
Iloperidone—HTR1D—female reproductive system—uterine cancer	0.000825	0.0166	CbGeAlD
Iloperidone—HTR7—renal system—uterine cancer	0.00082	0.0165	CbGeAlD
Iloperidone—HTR2C—female reproductive system—uterine cancer	0.000817	0.0164	CbGeAlD
Iloperidone—ADRA2C—uterine cervix—uterine cancer	0.000806	0.0162	CbGeAlD
Iloperidone—ADRA1A—renal system—uterine cancer	0.000791	0.0159	CbGeAlD
Iloperidone—ADRA2C—decidua—uterine cancer	0.000768	0.0154	CbGeAlD
Iloperidone—ADRA2C—renal system—uterine cancer	0.000754	0.0151	CbGeAlD
Iloperidone—ADRA2C—endometrium—uterine cancer	0.000729	0.0146	CbGeAlD
Iloperidone—ADRA2C—mammalian vulva—uterine cancer	0.000705	0.0142	CbGeAlD
Iloperidone—SIGMAR1—female gonad—uterine cancer	0.0007	0.014	CbGeAlD
Iloperidone—SIGMAR1—vagina—uterine cancer	0.000695	0.014	CbGeAlD
Iloperidone—Tremor—Progesterone—uterine cancer	0.000676	0.00292	CcSEcCtD
Iloperidone—CYP3A5—uterine cervix—uterine cancer	0.000675	0.0135	CbGeAlD
Iloperidone—ADRA2C—uterus—uterine cancer	0.000672	0.0135	CbGeAlD
Iloperidone—Anaemia—Progesterone—uterine cancer	0.000667	0.00288	CcSEcCtD
Iloperidone—Nystagmus—Epirubicin—uterine cancer	0.000662	0.00286	CcSEcCtD
Iloperidone—HRH1—epithelium—uterine cancer	0.00066	0.0133	CbGeAlD
Iloperidone—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000658	0.00284	CcSEcCtD
Iloperidone—HTR7—female reproductive system—uterine cancer	0.000657	0.0132	CbGeAlD
Iloperidone—HRH1—uterine cervix—uterine cancer	0.000655	0.0131	CbGeAlD
Iloperidone—CYP1A2—renal system—uterine cancer	0.000654	0.0131	CbGeAlD
Iloperidone—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000654	0.00283	CcSEcCtD
Iloperidone—Vertigo—Progesterone—uterine cancer	0.000648	0.0028	CcSEcCtD
Iloperidone—ADRA2A—uterine cervix—uterine cancer	0.000643	0.0129	CbGeAlD
Iloperidone—Palpitations—Progesterone—uterine cancer	0.000637	0.00276	CcSEcCtD
Iloperidone—HRH1—smooth muscle tissue—uterine cancer	0.000636	0.0128	CbGeAlD
Iloperidone—Stomatitis—Dactinomycin—uterine cancer	0.000636	0.00275	CcSEcCtD
Iloperidone—CYP3A5—renal system—uterine cancer	0.000631	0.0127	CbGeAlD
Iloperidone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000628	0.00272	CcSEcCtD
Iloperidone—Cardiac failure—Etoposide—uterine cancer	0.000628	0.00271	CcSEcCtD
Iloperidone—HRH1—decidua—uterine cancer	0.000624	0.0125	CbGeAlD
Iloperidone—Myalgia—Progesterone—uterine cancer	0.000614	0.00265	CcSEcCtD
Iloperidone—Arthralgia—Progesterone—uterine cancer	0.000614	0.00265	CcSEcCtD
Iloperidone—Nystagmus—Doxorubicin—uterine cancer	0.000613	0.00265	CcSEcCtD
Iloperidone—ADRA2A—decidua—uterine cancer	0.000613	0.0123	CbGeAlD
Iloperidone—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00265	CcSEcCtD
Iloperidone—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000604	0.00261	CcSEcCtD
Iloperidone—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000601	0.0026	CcSEcCtD
Iloperidone—Dry mouth—Progesterone—uterine cancer	0.000601	0.0026	CcSEcCtD
Iloperidone—Confusional state—Progesterone—uterine cancer	0.000594	0.00257	CcSEcCtD
Iloperidone—HRH1—endometrium—uterine cancer	0.000592	0.0119	CbGeAlD
Iloperidone—Oedema—Progesterone—uterine cancer	0.000589	0.00254	CcSEcCtD
Iloperidone—CYP2E1—renal system—uterine cancer	0.000589	0.0118	CbGeAlD
Iloperidone—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.00254	CcSEcCtD
Iloperidone—Infection—Progesterone—uterine cancer	0.000585	0.00253	CcSEcCtD
Iloperidone—ADRA2A—endometrium—uterine cancer	0.000582	0.0117	CbGeAlD
Iloperidone—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.0025	CcSEcCtD
Iloperidone—Nervous system disorder—Progesterone—uterine cancer	0.000577	0.0025	CcSEcCtD
Iloperidone—Tachycardia—Progesterone—uterine cancer	0.000575	0.00248	CcSEcCtD
Iloperidone—HRH1—mammalian vulva—uterine cancer	0.000573	0.0115	CbGeAlD
Iloperidone—Blood disorder—Epirubicin—uterine cancer	0.000566	0.00245	CcSEcCtD
Iloperidone—ADRA2A—mammalian vulva—uterine cancer	0.000563	0.0113	CbGeAlD
Iloperidone—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00241	CcSEcCtD
Iloperidone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00241	CcSEcCtD
Iloperidone—HTR2A—epithelium—uterine cancer	0.000552	0.0111	CbGeAlD
Iloperidone—Delirium—Epirubicin—uterine cancer	0.00055	0.00238	CcSEcCtD
Iloperidone—Hypotension—Progesterone—uterine cancer	0.00055	0.00238	CcSEcCtD
Iloperidone—ADRA2C—female gonad—uterine cancer	0.000549	0.011	CbGeAlD
Iloperidone—ADRA2C—vagina—uterine cancer	0.000546	0.011	CbGeAlD
Iloperidone—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000544	0.00235	CcSEcCtD
Iloperidone—Breast pain—Epirubicin—uterine cancer	0.000542	0.00234	CcSEcCtD
Iloperidone—Amenorrhoea—Epirubicin—uterine cancer	0.000538	0.00233	CcSEcCtD
Iloperidone—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000538	0.00233	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000536	0.00232	CcSEcCtD
Iloperidone—ADRA2A—uterus—uterine cancer	0.000536	0.0108	CbGeAlD
Iloperidone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000533	0.00231	CcSEcCtD
Iloperidone—HTR2A—smooth muscle tissue—uterine cancer	0.000531	0.0107	CbGeAlD
Iloperidone—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00053	0.00229	CcSEcCtD
Iloperidone—Paraesthesia—Progesterone—uterine cancer	0.000529	0.00229	CcSEcCtD
Iloperidone—Dyspnoea—Progesterone—uterine cancer	0.000525	0.00227	CcSEcCtD
Iloperidone—Blood disorder—Doxorubicin—uterine cancer	0.000524	0.00227	CcSEcCtD
Iloperidone—Somnolence—Progesterone—uterine cancer	0.000523	0.00226	CcSEcCtD
Iloperidone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.00226	CcSEcCtD
Iloperidone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00225	CcSEcCtD
Iloperidone—HTR2A—renal system—uterine cancer	0.000512	0.0103	CbGeAlD
Iloperidone—Delirium—Doxorubicin—uterine cancer	0.000509	0.0022	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000508	0.0022	CcSEcCtD
Iloperidone—Fatigue—Progesterone—uterine cancer	0.000508	0.00219	CcSEcCtD
Iloperidone—Dyskinesia—Epirubicin—uterine cancer	0.000503	0.00218	CcSEcCtD
Iloperidone—Breast pain—Doxorubicin—uterine cancer	0.000502	0.00217	CcSEcCtD
Iloperidone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000498	0.00215	CcSEcCtD
Iloperidone—Amenorrhoea—Doxorubicin—uterine cancer	0.000498	0.00215	CcSEcCtD
Iloperidone—HRH1—female reproductive system—uterine cancer	0.000491	0.00984	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.0021	CcSEcCtD
Iloperidone—Feeling abnormal—Progesterone—uterine cancer	0.000485	0.0021	CcSEcCtD
Iloperidone—Gait disturbance—Epirubicin—uterine cancer	0.000485	0.0021	CcSEcCtD
Iloperidone—ADRA2A—female reproductive system—uterine cancer	0.000482	0.00967	CbGeAlD
Iloperidone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000479	0.00207	CcSEcCtD
Iloperidone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000476	0.00206	CcSEcCtD
Iloperidone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000474	0.00205	CcSEcCtD
Iloperidone—CYP3A4—renal system—uterine cancer	0.000474	0.0095	CbGeAlD
Iloperidone—CYP2E1—female reproductive system—uterine cancer	0.000471	0.00946	CbGeAlD
Iloperidone—Anaemia—Dactinomycin—uterine cancer	0.000471	0.00204	CcSEcCtD
Iloperidone—CYP2D6—renal system—uterine cancer	0.000466	0.00935	CbGeAlD
Iloperidone—Dyskinesia—Doxorubicin—uterine cancer	0.000466	0.00201	CcSEcCtD
Iloperidone—Body temperature increased—Progesterone—uterine cancer	0.000465	0.00201	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00199	CcSEcCtD
Iloperidone—Stomatitis—Etoposide—uterine cancer	0.00046	0.00199	CcSEcCtD
Iloperidone—CYP3A5—female gonad—uterine cancer	0.00046	0.00923	CbGeAlD
Iloperidone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00046	0.00199	CcSEcCtD
Iloperidone—Salivary hypersecretion—Epirubicin—uterine cancer	0.000459	0.00199	CcSEcCtD
Iloperidone—CYP3A5—vagina—uterine cancer	0.000457	0.00917	CbGeAlD
Iloperidone—Leukopenia—Dactinomycin—uterine cancer	0.000456	0.00197	CcSEcCtD
Iloperidone—SIGMAR1—lymph node—uterine cancer	0.00045	0.00903	CbGeAlD
Iloperidone—Fluid retention—Epirubicin—uterine cancer	0.000449	0.00194	CcSEcCtD
Iloperidone—Gait disturbance—Doxorubicin—uterine cancer	0.000449	0.00194	CcSEcCtD
Iloperidone—Hepatobiliary disease—Etoposide—uterine cancer	0.000447	0.00193	CcSEcCtD
Iloperidone—HRH1—female gonad—uterine cancer	0.000446	0.00896	CbGeAlD
Iloperidone—HRH1—vagina—uterine cancer	0.000444	0.0089	CbGeAlD
Iloperidone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.0019	CcSEcCtD
Iloperidone—ADRA2A—female gonad—uterine cancer	0.000438	0.0088	CbGeAlD
Iloperidone—Dry eye—Epirubicin—uterine cancer	0.000437	0.00189	CcSEcCtD
Iloperidone—ADRA2A—vagina—uterine cancer	0.000436	0.00875	CbGeAlD
Iloperidone—Myalgia—Dactinomycin—uterine cancer	0.000434	0.00188	CcSEcCtD
Iloperidone—Mouth ulceration—Epirubicin—uterine cancer	0.000428	0.00185	CcSEcCtD
Iloperidone—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000425	0.00184	CcSEcCtD
Iloperidone—Asthenia—Progesterone—uterine cancer	0.000422	0.00183	CcSEcCtD
Iloperidone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000422	0.00182	CcSEcCtD
Iloperidone—Urinary tract disorder—Etoposide—uterine cancer	0.000419	0.00181	CcSEcCtD
Iloperidone—Oedema—Dactinomycin—uterine cancer	0.000416	0.0018	CcSEcCtD
Iloperidone—Fluid retention—Doxorubicin—uterine cancer	0.000416	0.0018	CcSEcCtD
Iloperidone—Urethral disorder—Etoposide—uterine cancer	0.000415	0.0018	CcSEcCtD
Iloperidone—Infection—Dactinomycin—uterine cancer	0.000413	0.00179	CcSEcCtD
Iloperidone—HTR2A—female reproductive system—uterine cancer	0.00041	0.00822	CbGeAlD
Iloperidone—Dry eye—Doxorubicin—uterine cancer	0.000404	0.00175	CcSEcCtD
Iloperidone—Diarrhoea—Progesterone—uterine cancer	0.000403	0.00174	CcSEcCtD
Iloperidone—Eye disorder—Etoposide—uterine cancer	0.000396	0.00171	CcSEcCtD
Iloperidone—Mouth ulceration—Doxorubicin—uterine cancer	0.000396	0.00171	CcSEcCtD
Iloperidone—Cardiac disorder—Etoposide—uterine cancer	0.000393	0.0017	CcSEcCtD
Iloperidone—Dizziness—Progesterone—uterine cancer	0.000389	0.00168	CcSEcCtD
Iloperidone—Angiopathy—Etoposide—uterine cancer	0.000385	0.00166	CcSEcCtD
Iloperidone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000383	0.00165	CcSEcCtD
Iloperidone—Mediastinal disorder—Etoposide—uterine cancer	0.000382	0.00165	CcSEcCtD
Iloperidone—CYP3A4—female reproductive system—uterine cancer	0.000379	0.00761	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000379	0.00164	CcSEcCtD
Iloperidone—CYP2D6—female reproductive system—uterine cancer	0.000373	0.00749	CbGeAlD
Iloperidone—Renal failure acute—Epirubicin—uterine cancer	0.000372	0.00161	CcSEcCtD
Iloperidone—Rash—Progesterone—uterine cancer	0.000371	0.0016	CcSEcCtD
Iloperidone—Dermatitis—Progesterone—uterine cancer	0.000371	0.0016	CcSEcCtD
Iloperidone—HTR2A—vagina—uterine cancer	0.000371	0.00744	CbGeAlD
Iloperidone—Increased appetite—Epirubicin—uterine cancer	0.000366	0.00158	CcSEcCtD
Iloperidone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000365	0.00158	CcSEcCtD
Iloperidone—Fatigue—Dactinomycin—uterine cancer	0.000359	0.00155	CcSEcCtD
Iloperidone—Muscle spasms—Etoposide—uterine cancer	0.000355	0.00153	CcSEcCtD
Iloperidone—ADRA2C—lymph node—uterine cancer	0.000353	0.00709	CbGeAlD
Iloperidone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00152	CcSEcCtD
Iloperidone—Cardiac failure—Epirubicin—uterine cancer	0.000352	0.00152	CcSEcCtD
Iloperidone—Lethargy—Epirubicin—uterine cancer	0.00035	0.00152	CcSEcCtD
Iloperidone—Nausea—Progesterone—uterine cancer	0.00035	0.00151	CcSEcCtD
Iloperidone—Renal failure acute—Doxorubicin—uterine cancer	0.000344	0.00149	CcSEcCtD
Iloperidone—Feeling abnormal—Dactinomycin—uterine cancer	0.000343	0.00148	CcSEcCtD
Iloperidone—Anaemia—Etoposide—uterine cancer	0.000341	0.00147	CcSEcCtD
Iloperidone—CYP2D6—female gonad—uterine cancer	0.00034	0.00682	CbGeAlD
Iloperidone—Increased appetite—Doxorubicin—uterine cancer	0.000338	0.00146	CcSEcCtD
Iloperidone—Affect lability—Epirubicin—uterine cancer	0.000338	0.00146	CcSEcCtD
Iloperidone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000336	0.00145	CcSEcCtD
Iloperidone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000336	0.00145	CcSEcCtD
Iloperidone—Vertigo—Etoposide—uterine cancer	0.000332	0.00143	CcSEcCtD
Iloperidone—Leukopenia—Etoposide—uterine cancer	0.00033	0.00143	CcSEcCtD
Iloperidone—Body temperature increased—Dactinomycin—uterine cancer	0.000329	0.00142	CcSEcCtD
Iloperidone—Cardiac failure—Doxorubicin—uterine cancer	0.000326	0.00141	CcSEcCtD
Iloperidone—Mood swings—Epirubicin—uterine cancer	0.000325	0.00141	CcSEcCtD
Iloperidone—Lethargy—Doxorubicin—uterine cancer	0.000324	0.0014	CcSEcCtD
Iloperidone—Dehydration—Epirubicin—uterine cancer	0.000319	0.00138	CcSEcCtD
Iloperidone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00137	CcSEcCtD
Iloperidone—Orthostatic hypotension—Epirubicin—uterine cancer	0.000314	0.00136	CcSEcCtD
Iloperidone—Affect lability—Doxorubicin—uterine cancer	0.000313	0.00135	CcSEcCtD
Iloperidone—Hypokalaemia—Epirubicin—uterine cancer	0.000313	0.00135	CcSEcCtD
Iloperidone—Breast disorder—Epirubicin—uterine cancer	0.00031	0.00134	CcSEcCtD
Iloperidone—Nasopharyngitis—Epirubicin—uterine cancer	0.000307	0.00133	CcSEcCtD
Iloperidone—Gastritis—Epirubicin—uterine cancer	0.000304	0.00131	CcSEcCtD
Iloperidone—Confusional state—Etoposide—uterine cancer	0.000304	0.00131	CcSEcCtD
Iloperidone—Mood swings—Doxorubicin—uterine cancer	0.000301	0.0013	CcSEcCtD
Iloperidone—Infection—Etoposide—uterine cancer	0.000299	0.00129	CcSEcCtD
Iloperidone—Asthenia—Dactinomycin—uterine cancer	0.000299	0.00129	CcSEcCtD
Iloperidone—Asthma—Epirubicin—uterine cancer	0.000297	0.00128	CcSEcCtD
Iloperidone—Dehydration—Doxorubicin—uterine cancer	0.000296	0.00128	CcSEcCtD
Iloperidone—Tachycardia—Etoposide—uterine cancer	0.000294	0.00127	CcSEcCtD
Iloperidone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00029	0.00125	CcSEcCtD
Iloperidone—Hypokalaemia—Doxorubicin—uterine cancer	0.000289	0.00125	CcSEcCtD
Iloperidone—Breast disorder—Doxorubicin—uterine cancer	0.000287	0.00124	CcSEcCtD
Iloperidone—HRH1—lymph node—uterine cancer	0.000287	0.00576	CbGeAlD
Iloperidone—Diarrhoea—Dactinomycin—uterine cancer	0.000285	0.00123	CcSEcCtD
Iloperidone—Nasopharyngitis—Doxorubicin—uterine cancer	0.000284	0.00123	CcSEcCtD
Iloperidone—ADRA2A—lymph node—uterine cancer	0.000282	0.00566	CbGeAlD
Iloperidone—Hypotension—Etoposide—uterine cancer	0.000281	0.00122	CcSEcCtD
Iloperidone—Gastritis—Doxorubicin—uterine cancer	0.000281	0.00122	CcSEcCtD
Iloperidone—Dysuria—Epirubicin—uterine cancer	0.000278	0.0012	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000276	0.00119	CcSEcCtD
Iloperidone—Asthma—Doxorubicin—uterine cancer	0.000275	0.00119	CcSEcCtD
Iloperidone—Pollakiuria—Epirubicin—uterine cancer	0.000274	0.00119	CcSEcCtD
Iloperidone—Paraesthesia—Etoposide—uterine cancer	0.00027	0.00117	CcSEcCtD
Iloperidone—Weight increased—Epirubicin—uterine cancer	0.00027	0.00117	CcSEcCtD
Iloperidone—Weight decreased—Epirubicin—uterine cancer	0.000269	0.00116	CcSEcCtD
Iloperidone—Dyspnoea—Etoposide—uterine cancer	0.000268	0.00116	CcSEcCtD
Iloperidone—Somnolence—Etoposide—uterine cancer	0.000268	0.00116	CcSEcCtD
Iloperidone—Rash—Dactinomycin—uterine cancer	0.000262	0.00113	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Etoposide—uterine cancer	0.00026	0.00112	CcSEcCtD
Iloperidone—Fatigue—Etoposide—uterine cancer	0.00026	0.00112	CcSEcCtD
Iloperidone—Stomatitis—Epirubicin—uterine cancer	0.000258	0.00112	CcSEcCtD
Iloperidone—Conjunctivitis—Epirubicin—uterine cancer	0.000257	0.00111	CcSEcCtD
Iloperidone—Dysuria—Doxorubicin—uterine cancer	0.000257	0.00111	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000255	0.0011	CcSEcCtD
Iloperidone—Pollakiuria—Doxorubicin—uterine cancer	0.000254	0.0011	CcSEcCtD
Iloperidone—Hepatobiliary disease—Epirubicin—uterine cancer	0.00025	0.00108	CcSEcCtD
Iloperidone—Weight increased—Doxorubicin—uterine cancer	0.00025	0.00108	CcSEcCtD
Iloperidone—Epistaxis—Epirubicin—uterine cancer	0.00025	0.00108	CcSEcCtD
Iloperidone—Weight decreased—Doxorubicin—uterine cancer	0.000248	0.00107	CcSEcCtD
Iloperidone—Feeling abnormal—Etoposide—uterine cancer	0.000248	0.00107	CcSEcCtD
Iloperidone—Nausea—Dactinomycin—uterine cancer	0.000247	0.00107	CcSEcCtD
Iloperidone—Stomatitis—Doxorubicin—uterine cancer	0.000239	0.00103	CcSEcCtD
Iloperidone—Body temperature increased—Etoposide—uterine cancer	0.000238	0.00103	CcSEcCtD
Iloperidone—Conjunctivitis—Doxorubicin—uterine cancer	0.000238	0.00103	CcSEcCtD
Iloperidone—Urinary tract disorder—Epirubicin—uterine cancer	0.000235	0.00101	CcSEcCtD
Iloperidone—Connective tissue disorder—Epirubicin—uterine cancer	0.000233	0.00101	CcSEcCtD
Iloperidone—Urethral disorder—Epirubicin—uterine cancer	0.000233	0.00101	CcSEcCtD
Iloperidone—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000232	0.001	CcSEcCtD
Iloperidone—Epistaxis—Doxorubicin—uterine cancer	0.000231	0.000999	CcSEcCtD
Iloperidone—Eye disorder—Epirubicin—uterine cancer	0.000222	0.00096	CcSEcCtD
Iloperidone—Tinnitus—Epirubicin—uterine cancer	0.000222	0.000958	CcSEcCtD
Iloperidone—Cardiac disorder—Epirubicin—uterine cancer	0.000221	0.000953	CcSEcCtD
Iloperidone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000217	0.000939	CcSEcCtD
Iloperidone—Asthenia—Etoposide—uterine cancer	0.000216	0.000934	CcSEcCtD
Iloperidone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000216	0.000934	CcSEcCtD
Iloperidone—Angiopathy—Epirubicin—uterine cancer	0.000216	0.000932	CcSEcCtD
Iloperidone—Urethral disorder—Doxorubicin—uterine cancer	0.000215	0.000932	CcSEcCtD
Iloperidone—Mediastinal disorder—Epirubicin—uterine cancer	0.000214	0.000926	CcSEcCtD
Iloperidone—Arrhythmia—Epirubicin—uterine cancer	0.000212	0.000918	CcSEcCtD
Iloperidone—Mental disorder—Epirubicin—uterine cancer	0.000208	0.0009	CcSEcCtD
Iloperidone—Malnutrition—Epirubicin—uterine cancer	0.000207	0.000894	CcSEcCtD
Iloperidone—Diarrhoea—Etoposide—uterine cancer	0.000206	0.000891	CcSEcCtD
Iloperidone—Eye disorder—Doxorubicin—uterine cancer	0.000205	0.000888	CcSEcCtD
Iloperidone—Tinnitus—Doxorubicin—uterine cancer	0.000205	0.000886	CcSEcCtD
Iloperidone—Cardiac disorder—Doxorubicin—uterine cancer	0.000204	0.000882	CcSEcCtD
Iloperidone—Angiopathy—Doxorubicin—uterine cancer	0.000199	0.000862	CcSEcCtD
Iloperidone—Dizziness—Etoposide—uterine cancer	0.000199	0.000861	CcSEcCtD
Iloperidone—Muscle spasms—Epirubicin—uterine cancer	0.000199	0.00086	CcSEcCtD
Iloperidone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000198	0.000857	CcSEcCtD
Iloperidone—Arrhythmia—Doxorubicin—uterine cancer	0.000196	0.000849	CcSEcCtD
Iloperidone—Vision blurred—Epirubicin—uterine cancer	0.000195	0.000843	CcSEcCtD
Iloperidone—Mental disorder—Doxorubicin—uterine cancer	0.000193	0.000833	CcSEcCtD
Iloperidone—Malnutrition—Doxorubicin—uterine cancer	0.000191	0.000827	CcSEcCtD
Iloperidone—Anaemia—Epirubicin—uterine cancer	0.000191	0.000826	CcSEcCtD
Iloperidone—Agitation—Epirubicin—uterine cancer	0.00019	0.000822	CcSEcCtD
Iloperidone—Rash—Etoposide—uterine cancer	0.00019	0.000821	CcSEcCtD
Iloperidone—Dermatitis—Etoposide—uterine cancer	0.00019	0.00082	CcSEcCtD
Iloperidone—Vertigo—Epirubicin—uterine cancer	0.000186	0.000803	CcSEcCtD
Iloperidone—Leukopenia—Epirubicin—uterine cancer	0.000185	0.0008	CcSEcCtD
Iloperidone—Muscle spasms—Doxorubicin—uterine cancer	0.000184	0.000795	CcSEcCtD
Iloperidone—Palpitations—Epirubicin—uterine cancer	0.000183	0.00079	CcSEcCtD
Iloperidone—Vision blurred—Doxorubicin—uterine cancer	0.00018	0.00078	CcSEcCtD
Iloperidone—Nausea—Etoposide—uterine cancer	0.000179	0.000773	CcSEcCtD
Iloperidone—Anaemia—Doxorubicin—uterine cancer	0.000177	0.000765	CcSEcCtD
Iloperidone—Arthralgia—Epirubicin—uterine cancer	0.000176	0.000761	CcSEcCtD
Iloperidone—Myalgia—Epirubicin—uterine cancer	0.000176	0.000761	CcSEcCtD
Iloperidone—Agitation—Doxorubicin—uterine cancer	0.000176	0.00076	CcSEcCtD
Iloperidone—Dry mouth—Epirubicin—uterine cancer	0.000172	0.000744	CcSEcCtD
Iloperidone—Vertigo—Doxorubicin—uterine cancer	0.000172	0.000743	CcSEcCtD
Iloperidone—Leukopenia—Doxorubicin—uterine cancer	0.000171	0.000741	CcSEcCtD
Iloperidone—Confusional state—Epirubicin—uterine cancer	0.00017	0.000736	CcSEcCtD
Iloperidone—Palpitations—Doxorubicin—uterine cancer	0.000169	0.000731	CcSEcCtD
Iloperidone—Oedema—Epirubicin—uterine cancer	0.000169	0.00073	CcSEcCtD
Iloperidone—Infection—Epirubicin—uterine cancer	0.000168	0.000725	CcSEcCtD
Iloperidone—Nervous system disorder—Epirubicin—uterine cancer	0.000166	0.000716	CcSEcCtD
Iloperidone—Tachycardia—Epirubicin—uterine cancer	0.000165	0.000712	CcSEcCtD
Iloperidone—Arthralgia—Doxorubicin—uterine cancer	0.000163	0.000704	CcSEcCtD
Iloperidone—Myalgia—Doxorubicin—uterine cancer	0.000163	0.000704	CcSEcCtD
Iloperidone—Dry mouth—Doxorubicin—uterine cancer	0.000159	0.000689	CcSEcCtD
Iloperidone—Hypotension—Epirubicin—uterine cancer	0.000158	0.000682	CcSEcCtD
Iloperidone—Confusional state—Doxorubicin—uterine cancer	0.000157	0.000681	CcSEcCtD
Iloperidone—Oedema—Doxorubicin—uterine cancer	0.000156	0.000675	CcSEcCtD
Iloperidone—Infection—Doxorubicin—uterine cancer	0.000155	0.000671	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000154	0.000665	CcSEcCtD
Iloperidone—Nervous system disorder—Doxorubicin—uterine cancer	0.000153	0.000662	CcSEcCtD
Iloperidone—Tachycardia—Doxorubicin—uterine cancer	0.000152	0.000659	CcSEcCtD
Iloperidone—Paraesthesia—Epirubicin—uterine cancer	0.000152	0.000655	CcSEcCtD
Iloperidone—Dyspnoea—Epirubicin—uterine cancer	0.00015	0.000651	CcSEcCtD
Iloperidone—Somnolence—Epirubicin—uterine cancer	0.00015	0.000649	CcSEcCtD
Iloperidone—Hypotension—Doxorubicin—uterine cancer	0.000146	0.000631	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000146	0.00063	CcSEcCtD
Iloperidone—Fatigue—Epirubicin—uterine cancer	0.000146	0.000629	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000142	0.000615	CcSEcCtD
Iloperidone—Paraesthesia—Doxorubicin—uterine cancer	0.00014	0.000606	CcSEcCtD
Iloperidone—Dyspnoea—Doxorubicin—uterine cancer	0.000139	0.000602	CcSEcCtD
Iloperidone—Feeling abnormal—Epirubicin—uterine cancer	0.000139	0.000601	CcSEcCtD
Iloperidone—Somnolence—Doxorubicin—uterine cancer	0.000139	0.0006	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000135	0.000583	CcSEcCtD
Iloperidone—Fatigue—Doxorubicin—uterine cancer	0.000135	0.000582	CcSEcCtD
Iloperidone—Body temperature increased—Epirubicin—uterine cancer	0.000133	0.000577	CcSEcCtD
Iloperidone—Feeling abnormal—Doxorubicin—uterine cancer	0.000129	0.000556	CcSEcCtD
Iloperidone—Body temperature increased—Doxorubicin—uterine cancer	0.000123	0.000534	CcSEcCtD
Iloperidone—Asthenia—Epirubicin—uterine cancer	0.000121	0.000524	CcSEcCtD
Iloperidone—Diarrhoea—Epirubicin—uterine cancer	0.000115	0.000499	CcSEcCtD
Iloperidone—Asthenia—Doxorubicin—uterine cancer	0.000112	0.000484	CcSEcCtD
Iloperidone—Dizziness—Epirubicin—uterine cancer	0.000112	0.000483	CcSEcCtD
Iloperidone—Diarrhoea—Doxorubicin—uterine cancer	0.000107	0.000462	CcSEcCtD
Iloperidone—Rash—Epirubicin—uterine cancer	0.000106	0.00046	CcSEcCtD
Iloperidone—Dermatitis—Epirubicin—uterine cancer	0.000106	0.00046	CcSEcCtD
Iloperidone—Dizziness—Doxorubicin—uterine cancer	0.000103	0.000447	CcSEcCtD
Iloperidone—Nausea—Epirubicin—uterine cancer	0.0001	0.000433	CcSEcCtD
Iloperidone—Rash—Doxorubicin—uterine cancer	9.85e-05	0.000426	CcSEcCtD
Iloperidone—Dermatitis—Doxorubicin—uterine cancer	9.84e-05	0.000425	CcSEcCtD
Iloperidone—Nausea—Doxorubicin—uterine cancer	9.28e-05	0.000401	CcSEcCtD
Iloperidone—ADRA2A—Signaling Pathways—ESR1—uterine cancer	1.39e-06	0.000231	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—AKT1—uterine cancer	1.39e-06	0.00023	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CDKN1B—uterine cancer	1.38e-06	0.00023	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—STK11—uterine cancer	1.38e-06	0.000229	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.38e-06	0.000229	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL2—uterine cancer	1.37e-06	0.000228	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—AKT1—uterine cancer	1.37e-06	0.000227	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EP300—uterine cancer	1.37e-06	0.000227	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.36e-06	0.000227	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—VEGFA—uterine cancer	1.35e-06	0.000225	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—VEGFA—uterine cancer	1.35e-06	0.000225	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL2—uterine cancer	1.35e-06	0.000224	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL2—uterine cancer	1.35e-06	0.000223	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—VEGFA—uterine cancer	1.34e-06	0.000223	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NRAS—uterine cancer	1.34e-06	0.000222	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NRAS—uterine cancer	1.34e-06	0.000222	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NRAS—uterine cancer	1.33e-06	0.00022	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—PIK3CA—uterine cancer	1.33e-06	0.00022	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CTNNB1—uterine cancer	1.32e-06	0.00022	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PTEN—uterine cancer	1.32e-06	0.00022	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL2—uterine cancer	1.32e-06	0.000219	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	1.32e-06	0.000219	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	1.32e-06	0.000219	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CTNNB1—uterine cancer	1.31e-06	0.000217	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ERBB2—uterine cancer	1.3e-06	0.000216	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VEGFA—uterine cancer	1.29e-06	0.000215	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ERBB2—uterine cancer	1.29e-06	0.000215	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.29e-06	0.000215	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PTEN—uterine cancer	1.29e-06	0.000214	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PTEN—uterine cancer	1.28e-06	0.000213	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—PIK3CA—uterine cancer	1.28e-06	0.000213	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	1.28e-06	0.000213	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NRAS—uterine cancer	1.28e-06	0.000212	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PTEN—uterine cancer	1.27e-06	0.000211	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—KRAS—uterine cancer	1.27e-06	0.00021	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—EP300—uterine cancer	1.26e-06	0.000209	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.26e-06	0.000209	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ERBB2—uterine cancer	1.26e-06	0.000209	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—uterine cancer	1.26e-06	0.000209	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	1.26e-06	0.000209	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—KRAS—uterine cancer	1.25e-06	0.000207	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—KRAS—uterine cancer	1.24e-06	0.000206	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—uterine cancer	1.24e-06	0.000206	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	1.23e-06	0.000205	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL8—uterine cancer	1.23e-06	0.000205	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.23e-06	0.000205	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EP300—uterine cancer	1.23e-06	0.000204	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL8—uterine cancer	1.23e-06	0.000204	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL2—uterine cancer	1.23e-06	0.000204	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—HRAS—uterine cancer	1.23e-06	0.000204	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—EP300—uterine cancer	1.22e-06	0.000203	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MTHFR—uterine cancer	1.22e-06	0.000203	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	1.22e-06	0.000203	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—HRAS—uterine cancer	1.22e-06	0.000203	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EP300—uterine cancer	1.21e-06	0.000202	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	1.2e-06	0.0002	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	1.2e-06	0.000199	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	1.19e-06	0.000198	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	1.19e-06	0.000198	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	1.19e-06	0.000197	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	1.19e-06	0.000197	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	1.17e-06	0.000194	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—uterine cancer	1.17e-06	0.000194	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	1.16e-06	0.000193	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	1.15e-06	0.000192	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NRAS—uterine cancer	1.15e-06	0.000191	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—KRAS—uterine cancer	1.15e-06	0.000191	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—uterine cancer	1.15e-06	0.000191	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—KRAS—uterine cancer	1.15e-06	0.000191	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.15e-06	0.00019	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	1.14e-06	0.00019	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ERBB2—uterine cancer	1.14e-06	0.00019	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	1.14e-06	0.00019	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—KRAS—uterine cancer	1.14e-06	0.00019	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	1.14e-06	0.000189	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NRAS—uterine cancer	1.14e-06	0.000189	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	1.13e-06	0.000188	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	1.13e-06	0.000188	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ERBB2—uterine cancer	1.12e-06	0.000187	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ERBB2—uterine cancer	1.12e-06	0.000186	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	1.12e-06	0.000186	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PTEN—uterine cancer	1.11e-06	0.000184	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PTEN—uterine cancer	1.1e-06	0.000183	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	1.1e-06	0.000183	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	1.1e-06	0.000183	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—KRAS—uterine cancer	1.1e-06	0.000183	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL8—uterine cancer	1.08e-06	0.00018	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—uterine cancer	1.08e-06	0.00018	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—uterine cancer	1.08e-06	0.000179	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—HRAS—uterine cancer	1.08e-06	0.000179	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PTEN—uterine cancer	1.07e-06	0.000178	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL8—uterine cancer	1.07e-06	0.000177	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL8—uterine cancer	1.06e-06	0.000177	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.06e-06	0.000177	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—STK11—uterine cancer	1.06e-06	0.000177	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—HRAS—uterine cancer	1.06e-06	0.000176	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EP300—uterine cancer	1.06e-06	0.000176	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CDKN1B—uterine cancer	1.06e-06	0.000176	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—PIK3CA—uterine cancer	1.06e-06	0.000176	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—HRAS—uterine cancer	1.06e-06	0.000176	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—PIK3CA—uterine cancer	1.06e-06	0.000175	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EP300—uterine cancer	1.05e-06	0.000175	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	1.05e-06	0.000174	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	1.05e-06	0.000174	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—uterine cancer	1.05e-06	0.000174	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	1.04e-06	0.000173	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTEN—uterine cancer	1.04e-06	0.000173	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	1.04e-06	0.000173	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	1.04e-06	0.000173	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CDKN1B—uterine cancer	1.04e-06	0.000173	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	1.04e-06	0.000172	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—uterine cancer	1.03e-06	0.000172	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	1.03e-06	0.000171	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—uterine cancer	1.03e-06	0.000171	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EP300—uterine cancer	1.02e-06	0.00017	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—uterine cancer	1.02e-06	0.00017	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	1.02e-06	0.00017	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—uterine cancer	1.02e-06	0.00017	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	1.02e-06	0.000169	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—uterine cancer	1.02e-06	0.000169	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—PIK3CA—uterine cancer	1.01e-06	0.000168	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	1.01e-06	0.000167	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—uterine cancer	1e-06	0.000166	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CTNNB1—uterine cancer	9.99e-07	0.000166	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—uterine cancer	9.97e-07	0.000166	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—EP300—uterine cancer	9.95e-07	0.000165	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—KRAS—uterine cancer	9.91e-07	0.000165	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NRAS—uterine cancer	9.9e-07	0.000164	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NRAS—uterine cancer	9.85e-07	0.000164	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	9.83e-07	0.000163	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CTNNB1—uterine cancer	9.81e-07	0.000163	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—HRAS—uterine cancer	9.78e-07	0.000162	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—uterine cancer	9.78e-07	0.000162	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—KRAS—uterine cancer	9.78e-07	0.000162	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—HRAS—uterine cancer	9.77e-07	0.000162	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PTEN—uterine cancer	9.74e-07	0.000162	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—HRAS—uterine cancer	9.71e-07	0.000161	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	9.7e-07	0.000161	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	9.7e-07	0.000161	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	9.64e-07	0.00016	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	9.63e-07	0.00016	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PTEN—uterine cancer	9.59e-07	0.000159	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NRAS—uterine cancer	9.58e-07	0.000159	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTEN—uterine cancer	9.58e-07	0.000159	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PTEN—uterine cancer	9.56e-07	0.000159	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTEN—uterine cancer	9.56e-07	0.000159	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—uterine cancer	9.5e-07	0.000158	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	9.47e-07	0.000157	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PTEN—uterine cancer	9.39e-07	0.000156	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	9.37e-07	0.000156	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—HRAS—uterine cancer	9.35e-07	0.000155	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—uterine cancer	9.35e-07	0.000155	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—uterine cancer	9.33e-07	0.000155	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PIK3CA—uterine cancer	9.33e-07	0.000155	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EP300—uterine cancer	9.29e-07	0.000154	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	9.16e-07	0.000152	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EP300—uterine cancer	9.14e-07	0.000152	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—EP300—uterine cancer	9.13e-07	0.000152	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EP300—uterine cancer	9.12e-07	0.000151	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.12e-07	0.000151	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—EP300—uterine cancer	9.11e-07	0.000151	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PIK3CA—uterine cancer	9.1e-07	0.000151	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PIK3CA—uterine cancer	9.06e-07	0.00015	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PIK3CA—uterine cancer	8.98e-07	0.000149	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EP300—uterine cancer	8.95e-07	0.000149	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	8.95e-07	0.000149	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—uterine cancer	8.81e-07	0.000146	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—uterine cancer	8.8e-07	0.000146	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PTEN—uterine cancer	8.72e-07	0.000145	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NRAS—uterine cancer	8.69e-07	0.000144	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—uterine cancer	8.69e-07	0.000144	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—uterine cancer	8.66e-07	0.000144	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—uterine cancer	8.64e-07	0.000143	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—uterine cancer	8.64e-07	0.000143	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—uterine cancer	8.63e-07	0.000143	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—uterine cancer	8.57e-07	0.000142	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NRAS—uterine cancer	8.55e-07	0.000142	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NRAS—uterine cancer	8.53e-07	0.000142	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—KRAS—uterine cancer	8.52e-07	0.000142	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	8.51e-07	0.000141	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	8.48e-07	0.000141	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—KRAS—uterine cancer	8.48e-07	0.000141	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—HRAS—uterine cancer	8.42e-07	0.00014	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NRAS—uterine cancer	8.37e-07	0.000139	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EP300—uterine cancer	8.32e-07	0.000138	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—HRAS—uterine cancer	8.31e-07	0.000138	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—uterine cancer	8.26e-07	0.000137	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—KRAS—uterine cancer	8.24e-07	0.000137	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—uterine cancer	7.99e-07	0.000133	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	7.88e-07	0.000131	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	7.83e-07	0.00013	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	7.79e-07	0.000129	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NRAS—uterine cancer	7.78e-07	0.000129	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—uterine cancer	7.62e-07	0.000127	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	7.57e-07	0.000126	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—uterine cancer	7.57e-07	0.000126	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—uterine cancer	7.53e-07	0.000125	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—KRAS—uterine cancer	7.48e-07	0.000124	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—uterine cancer	7.44e-07	0.000124	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—uterine cancer	7.4e-07	0.000123	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—KRAS—uterine cancer	7.36e-07	0.000122	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PIK3CA—uterine cancer	7.36e-07	0.000122	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—KRAS—uterine cancer	7.34e-07	0.000122	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—uterine cancer	7.34e-07	0.000122	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—uterine cancer	7.33e-07	0.000122	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HRAS—uterine cancer	7.24e-07	0.00012	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—KRAS—uterine cancer	7.21e-07	0.00012	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HRAS—uterine cancer	7.2e-07	0.00012	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HRAS—uterine cancer	7.01e-07	0.000116	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PIK3CA—uterine cancer	6.87e-07	0.000114	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTEN—uterine cancer	6.8e-07	0.000113	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	6.76e-07	0.000112	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PIK3CA—uterine cancer	6.76e-07	0.000112	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PIK3CA—uterine cancer	6.75e-07	0.000112	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PIK3CA—uterine cancer	6.74e-07	0.000112	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—KRAS—uterine cancer	6.7e-07	0.000111	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—uterine cancer	6.65e-07	0.00011	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	6.62e-07	0.00011	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—uterine cancer	6.54e-07	0.000109	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—uterine cancer	6.53e-07	0.000108	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—EP300—uterine cancer	6.48e-07	0.000108	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—uterine cancer	6.41e-07	0.000106	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—uterine cancer	6.39e-07	0.000106	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—uterine cancer	6.36e-07	0.000106	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HRAS—uterine cancer	6.36e-07	0.000106	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—HRAS—uterine cancer	6.26e-07	0.000104	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HRAS—uterine cancer	6.24e-07	0.000104	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—uterine cancer	6.19e-07	0.000103	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	6.15e-07	0.000102	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HRAS—uterine cancer	6.13e-07	0.000102	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—uterine cancer	6.01e-07	9.98e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—uterine cancer	5.95e-07	9.88e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTEN—uterine cancer	5.76e-07	9.56e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HRAS—uterine cancer	5.69e-07	9.45e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—uterine cancer	5.61e-07	9.32e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—uterine cancer	5.52e-07	9.17e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—uterine cancer	5.52e-07	9.17e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—uterine cancer	5.51e-07	9.16e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—uterine cancer	5.51e-07	9.15e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—EP300—uterine cancer	5.49e-07	9.12e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—uterine cancer	5.41e-07	8.98e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—uterine cancer	5.03e-07	8.35e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.79e-07	7.96e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTEN—uterine cancer	4.44e-07	7.38e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—EP300—uterine cancer	4.24e-07	7.04e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PIK3CA—uterine cancer	4.06e-07	6.75e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—uterine cancer	3.92e-07	6.5e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—uterine cancer	3.32e-07	5.51e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.13e-07	5.21e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—uterine cancer	2.56e-07	4.25e-05	CbGpPWpGaD
